ID   NZM018
AC   CVCL_S438
SY   NZM18
DR   Wikidata; Q54931537
RX   CelloPub=CLPUB00227;
RX   PubMed=32567790;
CC   Doubling time: 62.5 hours (CelloPub=CLPUB00227).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,21
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
RX   CelloPub=CLPUB00227;
RA   Daukste L.;
RT   "Mathematical modelling of cancer cell population dynamics.";
RL   Thesis PhD (2012); University of Canterbury; Christchurch; New Zealand.
//
RX   PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249;
RA   Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J.,
RA   Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S.,
RA   Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.;
RT   "Genomic and signalling pathway characterization of the NZM panel of
RT   melanoma cell lines: a valuable model for studying the impact of
RT   genetic diversity in melanoma.";
RL   Pigment Cell Melanoma Res. 34:136-143(2021).
//